Partnerships are integral to Hikma’s strategy. We remain focused on building an increasingly diverse specialty portfolio through acquisition and partnership, including licensing of NDA/ANDA, generic medicines and biosimilars to help put better health within reach, every day across our regions.

Also, we offer contract manufacturing capabilities leveraging the quality, reliability and flexibility of our manufacturing facilities. We operate 32 manufacturing plants across the US, Europe and the MENA region.

For all business development enquiries contact:
US and Canada: usbusinessdevelopment@hikma.com
Europe: EUBusinessDevelopment@Hikma.com